These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 504241)

  • 1. Metergoline and other peripheral serotonin antagonists inhibit prolactin secretion through mechanisms unrelated to serotonin.
    Lamberts SW; MacLeod RM
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):75-9. PubMed ID: 504241
    [No Abstract]   [Full Text] [Related]  

  • 2. Metergoline and cyproheptadine suppress prolactin release by a non-5-hydroxytryptaminergic, non-dopaminergic mechanism.
    Besser GM; Delitala G; Grossman A; Yeo T
    Br J Pharmacol; 1980 Sep; 70(1):5-7. PubMed ID: 7426830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine profile and therapeutic employment of a new prolactin-lowering drug, metergoline.
    Ferrari C; Reschini E; Peracchi M; Crosignani PG
    Gynecol Obstet Invest; 1980; 11(1):1-16. PubMed ID: 6248438
    [No Abstract]   [Full Text] [Related]  

  • 4. Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine.
    Horowski R
    Adv Neurol; 1982; 33():325-34. PubMed ID: 7055013
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of puerperal lactation by metergoline.
    Crosignani PG; Lombroso GC; Caccamo A; Reschini E; Peracchi M
    Obstet Gynecol; 1978 Jan; 51(1):113-5. PubMed ID: 619329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of two serotonin antagonists on prolactin and thyrotrophin secretion in man.
    Ferrari C; Paracchi A; Rondena M; Beck-Peccoz P; Faglia G
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):575-78. PubMed ID: 991435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone and prolactin release in acromegalic patients following metergoline administration.
    Delitala G; Masala A; Alagna S; Devilla L; Lotti G
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1382-6. PubMed ID: 1002821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects.
    Ferrari C; Caldara R; Rampini P; Telloli P; Romussi M; Bertazzoni A; Polloni G; Mattei A; Crosignani PG
    Metabolism; 1978 Oct; 27(10):1499-504. PubMed ID: 692379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats.
    Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F
    Eur J Pharmacol; 1980 Jan; 61(2):203-6. PubMed ID: 7353591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does metergoline selectively attenuate 5-HT mediated prolactin release?
    Ellis PM; Gartside SE; Ware CJ; Campling GM; Cowen PJ
    Psychopharmacology (Berl); 1991; 105(1):129-31. PubMed ID: 1745704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prolactin and ovarian function. Synthetic review and clinico-experimental research on an antiprolactin antiserotonin agent].
    Rendina M; Donadio C; Martore GB
    Patol Clin Ostet Ginecol; 1978; 6(4):196-207. PubMed ID: 680332
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
    Fuller RW; Snoddy HD
    Endocrinology; 1979 Oct; 105(4):923-8. PubMed ID: 477605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying the prolactin-lowering effect of meterogoline in the rat.
    Cocchi D; Locatelli V; Carminati R; Müller EE
    Life Sci; 1978 Sep; 23(9):927-36. PubMed ID: 703523
    [No Abstract]   [Full Text] [Related]  

  • 16. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
    Gartside SE; Cowen PJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):103-9. PubMed ID: 2163847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced changes of brain serotoninergic tone and insulin-induced growth hormone release in the dog.
    Locatelli V; Panerai AE; Cocchi D; Gil-Ad I; Mantegazza P; Secchi C; Müller EE
    Neuroendocrinology; 1978; 25(2):84-104. PubMed ID: 652121
    [No Abstract]   [Full Text] [Related]  

  • 18. [Response of isolated segments of hepatic arteries to serotonin in the presence of methergoline].
    Bettini V; Doni MG; Legrenzi E; Santoni G
    Boll Soc Ital Biol Sper; 1979 Aug; 55(16):1572-5. PubMed ID: 553541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
    Pontiroli AE; Castegnaro E; Vettaro MP; Viberti GC; Pozza G
    Acta Endocrinol (Copenh); 1977 Jan; 84(1):36-44. PubMed ID: 318788
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonin receptor antagonists block a natural, short term surge in serum growth hormone levels.
    Arnold MA; Fernstrom JD
    Endocrinology; 1978 Oct; 103(4):1159-63. PubMed ID: 744138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.